Get the Stockscreener App
2.08
0.97%
0.02
After Hours:
2.11
0.03
+1.44%
Bioaffinity Technologies Inc stock is traded at $2.08, with a volume of 55,868.
It is up +0.97% in the last 24 hours and up +38.67% over the past month.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
See More
Previous Close:
$2.06
Open:
$2.04
24h Volume:
55,868
Relative Volume:
0.49
Market Cap:
$27.92M
Revenue:
$321.50K
Net Income/Loss:
$-7.24M
P/E Ratio:
-1.1887
EPS:
-1.7498
Net Cash Flow:
$-5.72M
1W Performance:
+6.12%
1M Performance:
+38.67%
6M Performance:
+2.97%
1Y Performance:
+78.72%
1-Day Range:
$2.02
$2.10
1-Week Range:
$1.88
$2.2592
52-Week Range:
$1.13
$3.62
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Name
Bioaffinity Technologies Inc
Sector
Industry
Phone
210-698-5334
Address
22211 WEST INTERSTATE-10, SAN ANTONIO
Bioaffinity Technologies Inc Stock (BIAF) Latest News
bioAffinity Technologies (NASDAQ:BIAFW) Shares Up 9.3% - Defense World
Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis - BioSpace
Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis - Business Wire
BioAffinity Technologies Searching For New Finance Chief - MPO-mag
bioAffinity Technologies announces secondary offering of 1.8M shares - MSN
Ratios Reveal: Breaking Down BioAffinity Technologies Inc (BIAF)’s Financial Health - The Dwinnex
bioAffinity Technologies Announces CFO Transition and Appointment - TipRanks
BioAffinity Names Michael Edwards as Interim CFO - MarketWatch
bioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFO - Business Wire
bioAffinity Technologies (NASDAQ:BIAFW) Stock Price Up 7% - Defense World
Earnings roundup: Biglari hurt by investments; BioAffinity gains momentum - San Antonio Express-News
BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q2 2024 - InvestorPlace
SEC Form 424B3 filed by bioAffinity Technologies Inc. - Quantisnow
bioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung Sales - Manchestertimes
bioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung Sales - StockTitan
bioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung Sales - Yahoo Finance
BioAffinity Technologies, Inc. announced that it has received $1.302084 million in funding - Marketscreener.com
Head to Head Comparison: bioAffinity Technologies (NASDAQ:BIAF) & DNAPrint Genomics (OTCMKTS:DNAG) - Defense World
BIAFbioAffinity Technologies, Inc. Latest Stock News & Market Updates - StockTitan
bioAffinity Technologies Announces Closing of Registered Direct Offering, Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million - 01Net
WallachBeth Capital Announces Closing of bioAffinity Technologies Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million - Quantisnow
WallachBeth Capital Announces Closing of bioAffinity Technologies Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million - PR Newswire
bioAffinity Technologies Announces Closing of Registered Direct Offering, Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million - Business Wire
Post-Trade Analysis: BioAffinity Technologies Inc (BIAF) Slides -27.31, Closing at 1.73 - The Dwinnex
Nasdaq Tumbles 3%; US Economy Adds 114,000 Jobs In July - Benzinga
WallachBeth Capital Announces bioAffinity Technologies Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million - PR Newswire
Dow Dips Over 400 Points; Apple Posts Upbeat Earnings - Benzinga
bioAffinity Technologies Announces Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million - Manchestertimes
bioAffinity Technologies Announces Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million - Business Wire
Maxim Group Initiates Coverage on bioAffinity Technologies (NASDAQ:BIAF) - Defense World
Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire
Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Yahoo Finance
bioAffinity Technologies (NASDAQ:BIAF) Shares Up 7.2% - Defense World
BIAFWbioAffinity Technologies, Inc. Latest Stock News & Market Updates - StockTitan
bioAffinity raises forecast as CyPath Lung sales surge - Investing.com
bioAffinity raises forecast as CyPath Lung sales surge By Investing.com - Investing.com India
Hims & Hers health COO sells over $1 million in company stock By Investing.com - Investing.com UK
bioAffinity raises forecast as CyPath Lung sales surge - Investing.com India
bioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® Lung - Business Wire
bioAffinity raises forecast as CyPath Lung sales surge By Investing.com - Investing.com UK
See how much the CEOs of San Antonio’s top companies were paid as profits fell - San Antonio Express-News
BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire
BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Yahoo Finance
BIOAFFINITY TECHNOLOGIES, INC. : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K) - Marketscreener.com
Balance Sheet Insights: BioAffinity Technologies Inc (BIAF)'s Debt-to-Equity and Long-Term Debt/Eq Ratios – DWinneX - The Dwinnex
bioAffinity Technologies, Inc. (NASDAQ:BIAFW) Short Interest Update - Defense World
bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests - Business Wire
bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests - Yahoo Finance
BIOAFFINITY TECHNOLOGIES, INC. : Other Events, Financial Statements and Exhibits (form 8-K) - Marketscreener.com
bioAffinity Technologies Shareholders Back Future Growth PlansTipRanks.com - TipRanks
bioAffinity raises forecast as CyPath Lung sales surge By Investing.com - Investing.com
Bioaffinity Technologies Inc Stock (BIAF) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
1.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):